11,26 +4,45%
Year 2027
- March 11, 2027
Board of Directors’ Meeting to approve the draft annual financial statements and the Consolidated Financial Statements as of 31st December 2026
- March 12, 2027
Analysts and Investors Conference Call on the FY 2026 financial results
- April 28, 2027 (single call)
Shareholders’ Meeting to approve the draft annual financial statements as of December 31, 2026, and present the consolidated financial statements as of 31st December 2026
- May 13, 2027
Board of Directors’ Meeting to approve the additional consolidated financial information as of 31st March 2027
- May 14, 2027
Analysts and Investors Conference Call on the additional consolidated financial Information as of 31st March 2027
- September 9, 2027
Board of Directors’ Meeting to approve the consolidated half-year financial report as of 30th June 2027
- September 10, 2027
Analysts and Investors Conference Call on the consolidated half-year financial report as of 30th June 2027
- November 11, 2027
Board of Directors’ Meeting to approve the additional consolidated financial information as of 30th September 2027
- November 12, 2027
Analysts and Investors Conference Call on the additional consolidated financial information as of 30th September 2027
Year 2026
- March 12, 2026
Board of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2025
- March 13, 2026
Analysts and Investors Conference Call for Fiscal Year 2025
- April 28, 2026 (Single meeting)
Shareholders’ Meeting to approve the financial statements as of December 31, 2025, and to present the consolidated financial statements as of December 31, 2025
- May 14, 2026
Board of Directors meeting to approve the supplemental consolidated financial information as of March 31, 2026
- May 15, 2026
Analysts and Investors Conference Call: Additional Consolidated Financial Information as of March 31, 2026
- September 10, 2026
Board of Directors meeting to approve the consolidated semiannual financial report as of June 30, 2026
- September 11, 2026
Analyst and Investor Conference Call on the Consolidated Half-Year Financial Report as of June 30, 2026
- November 12, 2026
Board of Directors meeting to approve the additional consolidated financial information as of September 30, 2026
- November 13, 2026
Analyst and Investor Conference Call: Additional Consolidated Financial Information as of September 30, 2026
Year 2025
- March 12, 2025
Board of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2024
- March 12, 2025
Analysts and Investors Conference Call for Fiscal Year 2024
- April 28, 2025 (single meeting)
Shareholders’ Meeting to approve the financial statements as of December 31, 2024, and to present the consolidated financial statements as of December 31, 2024
- May 14, 2025
Board of Directors meeting to approve the supplemental consolidated financial information as of March 31, 2025
- May 15, 2025
Analyst and Investor Conference Call: Additional Consolidated Financial Information as of March 31, 2025
- September 11, 2025
Board of Directors meeting to approve the consolidated semiannual financial report as of June 30, 2025
- September 12, 2025
Analyst and Investor Conference Call on the Consolidated Half-Year Financial Report as of June 30, 2025
- November 13, 2025
Board of Directors meeting to approve the additional consolidated financial information as of September 30, 2025
- November 14, 2025
Analyst and Investor Conference Call: Additional Consolidated Financial Information as of September 30, 2025
Year 2024
- February 2, 2024
Board of Directors meeting to approve the preliminary results as of December 31, 2023
- March 14, 2024
Board of Directors meeting to approve the draft annual financial statements and consolidated financial statements as of December 31, 2023
- March 15, 2024
FY 2023 Analyst and Investor Conference Call
- April 22, 2024 (1st meeting)
Shareholders’ Meeting for the approval of the financial statements as at 31 December 2023 and presentation of the consolidated financial statements as at 31 December 2023
- April 22, 2024 (2nd meeting)
Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2023 and presentation of the consolidated financial statements as at 31 December 2023
- May 14, 2024
Board of Directors’ Meeting for the approval of the additional consolidated financial information as at 31 March 2024
- May 15, 2024
Analysts and Investors Conference Call – Additional Consolidated Financial Information as at 31 March 2024
- September 12, 2024
Board of Directors’ Meeting for the approval of the consolidated half-year financial report as at 30 June 2024
- September 13, 2024
Analysts and Investors Conference Call – Consolidated Half-Year Financial Report as at 30 June 2024
- November 12, 2024
Board of Directors’ Meeting for the approval of the additional consolidated financial information as at 30 September 2024
- November 13, 2024
Analysts and Investors Conference Call – Additional Consolidated Financial Information as at 30 September 2024
Year 2023
- March 23, 2023
Board of Directors’ Meeting for the approval of the draft financial statements for the year ended 31 December 2022
- March 24, 2023
Analysts and Investors Conference Call – FY 2022
- April 27, 2023 (1st meeting)
Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2022
- April 28, 2023 (2nd meeting)
Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2022
- September 13, 2023
Board of Directors’ Meeting for the approval of the Half-Year Financial Report as at 30 June 2023
- September 14, 2023
Analysts and Investors Conference Call – H1 2023
- November 14, 2023
Board of Directors’ Meeting for the approval of the Interim Management Report as at 30 September 2023
- November 15, 2023
Analysts and Investors Conference Call – Q3 2023
Year 2022
- March 17, 2022
Board of Directors’ Meeting for the approval of the draft financial statements for the year ended 31 December 2021
- March 18, 2022
Analysts and Investors Conference Call – FY 2021
- April 14, 2022 (1st meeting)
Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2021
- April 19, 2022 (2nd meeting)
Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2021
- September 21, 2022
Board of Directors’ Meeting for the approval of the Half-Year Financial Report as at 30 June 2022
- September 22, 2022
Analysts and Investors Conference Call – H1 2022
Year 2021
- February 26, 2021
Board of Directors’ Meeting for the approval of the draft financial statements for the year ended 31 December 2020
- March 31, 2021 (1st meeting)
Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2020
- September 22, 2021
Board of Directors’ Meeting for the approval of the Half-Year Financial Report as at 30 June 2021
- September 23, 2021
Analysts and Investors Conference Call – H1 2021
Year 2020
- September 22, 2020
Board of Directors’ approval of the Half-Year Financial Report as at 30 June 2020
This post is also available in:
Italian